Revvity Inc vs Vanguard Information Technology Index Fund ETF — how do they compare? Revvity Inc trades at $124.14 (market cap $13.82B), while Vanguard Information Technology Index Fund ETF trades at $120.63. The key difference: Revvity Inc pays a 0.23% dividend while Vanguard Information Technology Index Fund ETF pays none. Which is the better fit depends on your goals.
| RVTY | VGT | |
|---|---|---|
Market Cap | $13.82B | — |
Sector | Technology | — |
52-Week High | $130.94 | $125.77 |
52-Week Low | $82.26 | $83.59 |
Enterprise Value | $16.14B | — |
Dividend Yield | 0.23% | — |
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
VGT trades at $121.05, showing modest daily weakness with a 0.18% decline. Technical indicators signal a bullish trend with strong moving average support, while oscillators remain neutral. Recent institutional buying activity from firms like Arcus Capital Partners and Guardian Wealth Advisors highlights strong professional interest in the technology ETF.
The ETF's concentrated exposure to AI leaders like Nvidia and Broadcom provides growth potential but also concentration risk. While technical momentum remains positive, investors should monitor semiconductor sector volatility and competitive pressures within the technology landscape that could impact future returns.
Trailing returns across standard periods
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →